Search Results - "BUSH, Ashley I"

Refine Results
  1. 1

    Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics by Belaidi, Abdel A., Bush, Ashley I.

    Published in Journal of neurochemistry (01-10-2016)
    “…Brain iron homeostasis is increasingly recognized as a potential target for the development of drug therapies for aging‐related disorders. Dysregulation of…”
    Get full text
    Journal Article
  2. 2

    Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration by Masaldan, Shashank, Bush, Ashley I., Devos, David, Rolland, Anne Sophie, Moreau, Caroline

    Published in Free radical biology & medicine (01-03-2019)
    “…Perturbations in iron homeostasis and iron accumulation feature in several neurodegenerative disorders including Alzheimer's disease (AD), Parkinson's disease…”
    Get full text
    Journal Article
  3. 3

    Biological metals and metal-targeting compounds in major neurodegenerative diseases by Barnham, Kevin J, Bush, Ashley I

    Published in Chemical Society reviews (01-01-2014)
    “…Multiple abnormalities occur in the homeostasis of essential endogenous brain biometals in age-related neurodegenerative disorders, Alzheimer's disease,…”
    Get more information
    Journal Article
  4. 4

    Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease by Jakaria, Md, Belaidi, Abdel Ali, Bush, Ashley I., Ayton, Scott

    Published in Journal of neurochemistry (01-12-2021)
    “…Alzheimer's disease (AD) is the most prevalent form of dementia, with complex pathophysiology that is not fully understood. While β‐amyloid plaque and…”
    Get full text
    Journal Article
  5. 5

    Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases by Furtado, Denzil, Björnmalm, Mattias, Ayton, Scott, Bush, Ashley I., Kempe, Kristian, Caruso, Frank

    Published in Advanced materials (Weinheim) (01-11-2018)
    “…Therapies directed toward the central nervous system remain difficult to translate into improved clinical outcomes. This is largely due to the blood–brain…”
    Get full text
    Journal Article
  6. 6

    Treating Alzheimer's disease by targeting iron by Nikseresht, Sara, Bush, Ashley I., Ayton, Scott

    Published in British journal of pharmacology (01-09-2019)
    “…No disease modifying drugs have been approved for Alzheimer's disease despite recent major investments by industry and governments throughout the world. The…”
    Get full text
    Journal Article
  7. 7

    Zinc in the physiology and pathology of the CNS by Sensi, Stefano L, Paoletti, Pierre, Bush, Ashley I, Sekler, Israel

    Published in Nature reviews. Neuroscience (01-11-2009)
    “…Key Points The development of new imaging tools and transgenic animals has greatly improved our understanding of the physiological and pathophysiological role…”
    Get full text
    Journal Article
  8. 8

    Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease by Lane, Darius J R, Metselaar, Billie, Greenough, Mark, Bush, Ashley I, Ayton, Scott J

    Published in Essays in biochemistry (22-12-2021)
    “…Ferroptosis is an iron- and lipid peroxidation-dependent cell death modality and emerging evidence indicates that ferroptosis has great explanatory potential…”
    Get more information
    Journal Article
  9. 9

    Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics by Duce, James A, Bush, Ashley I

    Published in Progress in neurobiology (01-09-2010)
    “…The equilibrium of metal ions is critical for many physiological functions, particularly in the central nervous system, where metals are essential for…”
    Get full text
    Journal Article
  10. 10

    Molecular Mechanisms of Glutaredoxin Enzymes: Versatile Hubs for Thiol–Disulfide Exchange between Protein Thiols and Glutathione by Xiao, Zhiguang, La Fontaine, Sharon, Bush, Ashley I., Wedd, Anthony G.

    Published in Journal of molecular biology (18-01-2019)
    “…The tripeptide glutathione (GSH) and its oxidized form glutathione disulfide (GSSG) constitute a key redox couple in cells. In particular, they partner protein…”
    Get full text
    Journal Article
  11. 11

    Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathology by Diouf, Ibrahima, Bush, Ashley I., Ayton, Scott

    Published in Neurobiology of disease (01-06-2020)
    “…The mechanisms leading to neurodegeneration in Alzheimer's disease (AD) may involve oxidative stress and neuroinflammation. Ceruloplasmin (Cp) is a circulating…”
    Get full text
    Journal Article
  12. 12

    Therapeutics for Alzheimer's Disease Based on the Metal Hypothesis by Bush, Ashley I., Tanzi, Rudolph E.

    Published in Neurotherapeutics (01-07-2008)
    “…Alzheimer's disease is the most common form of dementia in the elderly, and it is characterized by elevated brain iron levels and accumulation of copper and…”
    Get full text
    Journal Article
  13. 13

    The neurophysiology and pathology of brain zinc by Sensi, Stefano L, Paoletti, Pierre, Koh, Jae-Young, Aizenman, Elias, Bush, Ashley I, Hershfinkel, Michal

    Published in The Journal of neuroscience (09-11-2011)
    “…Our understanding of the roles played by zinc in the physiological and pathological functioning of the brain is rapidly expanding. The increased availability…”
    Get full text
    Journal Article
  14. 14

    Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis by Masaldan, Shashank, Clatworthy, Sharnel A.S., Gamell, Cristina, Meggyesy, Peter M., Rigopoulos, Antonia-Tonia, Haupt, Sue, Haupt, Ygal, Denoyer, Delphine, Adlard, Paul A., Bush, Ashley I., Cater, Michael A.

    Published in Redox biology (01-04-2018)
    “…Cellular senescence is characterised by the irreversible arrest of proliferation, a pro-inflammatory secretory phenotype and evasion of programmed cell death…”
    Get full text
    Journal Article
  15. 15

    Copper in the brain and Alzheimer's disease by Hung, Ya Hui, Bush, Ashley I, Cherny, Robert Alan

    Published in Journal of biological inorganic chemistry (01-01-2010)
    “…Alzheimer's disease (AD) is the most common form of neurodegenerative disease. The brain is particularly vulnerable to oxidative damage induced by unregulated…”
    Get full text
    Journal Article
  16. 16

    CuII(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease by Southon, Adam, Szostak, Kathryn, Acevedo, Karla M., Dent, Krista A., Volitakis, Irene, Belaidi, Abdel A., Barnham, Kevin J., Crouch, Peter J., Ayton, Scott, Donnelly, Paul S., Bush, Ashley I.

    Published in British journal of pharmacology (01-02-2020)
    “…Background and Purpose Diacetyl‐bis(4‐methyl‐3‐thiosemicarbazonato)copperII (CuII(atsm)) ameliorates neurodegeneration and delays disease progression in mouse…”
    Get full text
    Journal Article
  17. 17

    Cerebrospinal fluid ferritin levels predict brain hypometabolism in people with underlying β-amyloid pathology by Diouf, Ibrahima, Fazlollahi, Amir, Bush, Ashley I., Ayton, Scott

    Published in Neurobiology of disease (01-04-2019)
    “…β-Amyloid pathology is elevated in ~30% of cognitively normal people over 65, and is associated with accelerated neurodegeneration in the pre-clinical stages…”
    Get full text
    Journal Article
  18. 18

    Selenium, selenoproteins and neurodegenerative diseases by Cardoso, Bárbara Rita, Roberts, Blaine R, Bush, Ashley I, Hare, Dominic J

    Published in Metallomics (01-08-2015)
    “…It is unsurprising that our understanding of the role of selenium in neurological function is somewhat immature, considering its relatively recent discovery as…”
    Get full text
    Journal Article
  19. 19

    Iron as a therapeutic target for Parkinson's disease by Moreau, Caroline, Duce, James A., Rascol, Olivier, Devedjian, Jean‐Christophe, Berg, Daniela, Dexter, David, Cabantchik, Z. Ioav, Bush, Ashley I., Devos, David

    Published in Movement disorders (01-04-2018)
    “…An urgent need for efficacious disease modifying therapies is required to slow downParkinson’s disease (PD) progression. Iron is required as a cofactor in…”
    Get full text
    Journal Article
  20. 20

    Cognitive Loss in Zinc Transporter-3 Knock-Out Mice: A Phenocopy for the Synaptic and Memory Deficits of Alzheimer's Disease? by Adlard, Paul A, Parncutt, Jacqui M, Finkelstein, David I, Bush, Ashley I

    Published in The Journal of neuroscience (03-02-2010)
    “…Zinc transporter-3 (ZnT3) protein controls synaptic vesicular Zn(2+) levels, which is predicted to regulate normal cognitive function. Surprisingly, previous…”
    Get full text
    Journal Article